skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Escalation of radiation dose beyond 30 Gy in 10 fractions for metastatic spinal cord compression

Abstract

Purpose: In many centers worldwide, radiotherapy for metastatic spinal cord compression (MSCC) is performed with 30 Gy in 10 fractions. This study investigated the potential benefit of dose escalation. Methods and Materials: Data from 922 patients with carcinomas causing MSCC were retrospectively evaluated. The outcome of 345 patients treated with 10 fractions of 3 Gy in 2 weeks was compared with the outcomes of 577 patients treated with 37.5 Gy in 15 fractions within 3 weeks or 40 Gy in 20 fractions within 4 weeks. Additionally, 10 potential prognostic factors were investigated: age, gender, performance status, tumor type, interval between cancer diagnosis and MSCC, number of involved vertebrae, other bone and visceral metastases, ambulatory status, and the interval to the development of motor deficits before radiotherapy. Results: Motor function improved in 19% of patients after 30 Gy in 10 fractions and in 22% after greater doses (p = 0.31). The local control (p = 0.28) and survival (p = 0.85) rates were not significantly different with doses >30 Gy. Better functional outcome was associated with the absence of visceral metastases, an interval between tumor diagnosis and MSCC of >12 months, ambulatory status, and an interval to the development of motormore » deficits of >7 days. Improved local control was significantly associated with no visceral metastases, improved survival with favorable histologic features (breast or prostate cancer), no visceral metastases, ambulatory status, an interval between cancer diagnosis and MSCC of >12 months, and an interval to the development of motor deficits of >7days. Conclusion: Escalation of the radiation dose to >30 Gy in 10 fractions did not improve the outcomes in terms of motor function, local control, or survival but did increase the treatment time for these frequently debilitated patients. Therefore, doses >30 Gy in 10 fractions are not recommended.« less

Authors:
 [1];  [2];  [3];  [4];  [5];  [6];  [7]
  1. Department of Radiation Oncology, University Hospital Schleswig-Holstein, Luebeck (Germany) and Department of Radiation Oncology, University Hospital Hamburg-Eppendorf, Hamburg (Germany). E-mail: Rades.Dirk@gmx.net
  2. Department of Radiation Oncology, Hannover Medical School, Hannover (Germany)
  3. Mount Vernon Centre for Cancer Treatment, Northwood, Middlesex (United Kingdom)
  4. Department of Radiation Oncology, St. Josef Hospital, Ruhr University, Bochum (Germany)
  5. Department of Radiation Oncology, Dr. Bernard Verbeeten Institute, Tilburg (Netherlands)
  6. Department of Radiation Oncology, Mayo Clinic Scottsdale, Scottsdale, Arizona (United States)
  7. Department of Radiation Oncology, University Hospital Schleswig-Holstein, Luebeck (Germany)
Publication Date:
OSTI Identifier:
20944697
Resource Type:
Journal Article
Resource Relation:
Journal Name: International Journal of Radiation Oncology, Biology and Physics; Journal Volume: 67; Journal Issue: 2; Other Information: DOI: 10.1016/j.ijrobp.2006.09.025; PII: S0360-3016(06)02994-4; Copyright (c) 2007 Elsevier Science B.V., Amsterdam, Netherlands, All rights reserved; Country of input: International Atomic Energy Agency (IAEA)
Country of Publication:
United States
Language:
English
Subject:
62 RADIOLOGY AND NUCLEAR MEDICINE; CARCINOMAS; DIAGNOSIS; MAMMARY GLANDS; METASTASES; PATIENTS; PROSTATE; RADIATION DOSES; RADIOTHERAPY; SPINAL CORD; VERTEBRAE

Citation Formats

Rades, Dirk, Karstens, Johann H., Hoskin, Peter J., Rudat, Volker, Veninga, Theo, Schild, Steven E., and Dunst, Juergen. Escalation of radiation dose beyond 30 Gy in 10 fractions for metastatic spinal cord compression. United States: N. p., 2007. Web. doi:10.1016/j.ijrobp.2006.09.025.
Rades, Dirk, Karstens, Johann H., Hoskin, Peter J., Rudat, Volker, Veninga, Theo, Schild, Steven E., & Dunst, Juergen. Escalation of radiation dose beyond 30 Gy in 10 fractions for metastatic spinal cord compression. United States. doi:10.1016/j.ijrobp.2006.09.025.
Rades, Dirk, Karstens, Johann H., Hoskin, Peter J., Rudat, Volker, Veninga, Theo, Schild, Steven E., and Dunst, Juergen. Thu . "Escalation of radiation dose beyond 30 Gy in 10 fractions for metastatic spinal cord compression". United States. doi:10.1016/j.ijrobp.2006.09.025.
@article{osti_20944697,
title = {Escalation of radiation dose beyond 30 Gy in 10 fractions for metastatic spinal cord compression},
author = {Rades, Dirk and Karstens, Johann H. and Hoskin, Peter J. and Rudat, Volker and Veninga, Theo and Schild, Steven E. and Dunst, Juergen},
abstractNote = {Purpose: In many centers worldwide, radiotherapy for metastatic spinal cord compression (MSCC) is performed with 30 Gy in 10 fractions. This study investigated the potential benefit of dose escalation. Methods and Materials: Data from 922 patients with carcinomas causing MSCC were retrospectively evaluated. The outcome of 345 patients treated with 10 fractions of 3 Gy in 2 weeks was compared with the outcomes of 577 patients treated with 37.5 Gy in 15 fractions within 3 weeks or 40 Gy in 20 fractions within 4 weeks. Additionally, 10 potential prognostic factors were investigated: age, gender, performance status, tumor type, interval between cancer diagnosis and MSCC, number of involved vertebrae, other bone and visceral metastases, ambulatory status, and the interval to the development of motor deficits before radiotherapy. Results: Motor function improved in 19% of patients after 30 Gy in 10 fractions and in 22% after greater doses (p = 0.31). The local control (p = 0.28) and survival (p = 0.85) rates were not significantly different with doses >30 Gy. Better functional outcome was associated with the absence of visceral metastases, an interval between tumor diagnosis and MSCC of >12 months, ambulatory status, and an interval to the development of motor deficits of >7 days. Improved local control was significantly associated with no visceral metastases, improved survival with favorable histologic features (breast or prostate cancer), no visceral metastases, ambulatory status, an interval between cancer diagnosis and MSCC of >12 months, and an interval to the development of motor deficits of >7days. Conclusion: Escalation of the radiation dose to >30 Gy in 10 fractions did not improve the outcomes in terms of motor function, local control, or survival but did increase the treatment time for these frequently debilitated patients. Therefore, doses >30 Gy in 10 fractions are not recommended.},
doi = {10.1016/j.ijrobp.2006.09.025},
journal = {International Journal of Radiation Oncology, Biology and Physics},
number = 2,
volume = 67,
place = {United States},
year = {Thu Feb 01 00:00:00 EST 2007},
month = {Thu Feb 01 00:00:00 EST 2007}
}